Who founded Auxergen?

Auxergen was founded by Ting-Yu Yeh.

How much funding has Auxergen raised?

Auxergen has disclosed $535K raised across 1 round.

Where is Auxergen headquartered?

Auxergen is headquartered in Balitmore, US.

Auxergen

Balitmore, US · Delaware corporation

Auxergen is an agricultural biotechnology R&D company developing biological treatments such as CitriPhage for citrus canker, bio-treatments for Olive Quick Decline Syndrome, and bioremediation and phage-based technologies. It operates within the University of Maryland incubator system and serves agriculture, human health, and environmental sustainability markets, with international operations including a subsidiary in Bari, Italy.

AgTech Biotech Cleantech Climate Tech

Founders & leadership

Ting-Yu YehCo-founder & Chief Science Officer

Ting Yu-YehNamed on SEC filing

Gregory ContrerasCEO & Co-founder

Reported raises · per SEC filings

Form D private placements

$535K disclosed across 1 round · 2021

▶$535KraisedMay 2023 · 11 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Ting Yu-YehExecutive Officer, Director
Gregory ContrerasExecutive Officer, Director

Offering amount: $1M
Amount sold: $535K
Minimum investment: $25K
Proceeds to insiders: $420K
First sale: Apr 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 7

by search overlap

Biogen Idec5 shared keywordsBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.

Urogen4 shared keywordsUroGen is a biopharmaceutical company developing and commercializing treatments for urological cancers, including FDA-approved therapies such as JELMYTO and ZUSDURI built on its RTGel technology. Its pipeline focuses on uro-oncology indications like non-muscle invasive bladder cancer.

Solugen4 shared keywordsSolugen develops a biomanufacturing platform using fermentation and bioprocessing technology to produce specialty chemicals at scale. The company serves customers in energy, chemicals, and related industries with cost-effective alternatives to traditional petrochemical-based manufacturing.

Wugen4 shared keywordsAllotera (formerly Wugen) develops allogeneic T-cell therapies. The company focuses on cell and gene therapy approaches for treating disease.

Macrogenics Inc3 shared keywordsMacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.

Vizgen3 shared keywordsVizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples. The company serves research and diagnostic laboratories in the life sciences and precision oncology fields.

Cullgen3 shared keywordsCullgen is a privately held biopharmaceutical company developing first-in-class drugs based on its uSMITE™ (small-molecule induced ubiquitin-dependent target elimination) targeted protein degradation platform, which uses the ubiquitin-proteasome system and E3 ubiquitin ligases to target disease-causing proteins that conventional small-molecule drugs cannot reach. The company focuses on oncology and immune-related diseases and operates R&D and offices in both China and the United States.

Companies competing with Auxergen for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Auxergen do?: Auxergen is an agricultural biotechnology R&D company developing biological treatments such as CitriPhage for citrus canker, bio-treatments for Olive Quick Decline Syndrome, and bioremediation and phage-based technologies. It operates within the University of Maryland incubator system and serves agriculture, human health, and environmental sustainability markets, with international operations including a subsidiary in Bari, Italy.
Who founded Auxergen?: Auxergen was founded by Ting-Yu Yeh.
How much funding has Auxergen raised?: Auxergen has disclosed $535K raised across 1 round.
Where is Auxergen headquartered?: Auxergen is headquartered in Balitmore, US.